Form 4: KeyCorp Director Robin Hayes Adjusts Holdings

Sentiment:

Insider Transaction Report


KeyCorp Director Robin Hayes reported the acquisition of deferred shares and the conversion of deferred shares into common stock under a pre-arranged plan.

Summary

  • Director Robin Hayes acquired 1,453 deferred shares on December 31, 2025, which are economically equivalent to common shares, at a price of $20.64 per share.
  • These deferred shares include approximately 615 dividend-equivalent deferred shares accrued in December 2025.
  • Payment for these deferred shares is scheduled for the earlier of January 1, 2028, or the participant's death.
  • On January 1, 2026, 3,174 deferred shares were exercised and converted into 3,174 common shares.
  • Following these transactions, Robin Hayes directly holds 25,723 common shares and 60,233 deferred shares.
  • All reported transactions were conducted under a Rule 10b5-1 pre-arranged trading plan.

Sentiment

Score: 6

Explanation: Neutral to slightly positive. The filing reports routine insider transactions, including an acquisition of deferred shares, which aligns director interests with shareholders. The use of a 10b5-1 plan indicates good governance. No significant negative events are disclosed.

Positives

  • The acquisition of 1,453 deferred shares by a director indicates continued alignment of interests with shareholders.
  • The transactions were executed under a Rule 10b5-1 plan, suggesting pre-planned and orderly management of insider holdings.

Negatives

  • No direct negatives are apparent from this Form 4 filing, as it primarily reports routine insider transactions.

Risks

  • No specific risks are mentioned in this Form 4 filing.

Future Outlook

The filing indicates future payment of deferred shares by January 1, 2028, or upon the participant's death, as per the Deferred Share Plan terms.

Management Comments

  • Each Deferred Share is the economic equivalent of one Common Share.
  • Directors may elect to defer the payment of directors' fees into the Amended and Restated Directors' Deferred Share Sub-Plan to the KeyCorp Amended and Restated 2019 Equity Compensation Plan.
  • Under the terms of the Deferred Share Plan, payment of the deferred shares has been deferred until the earlier of January 1, 2028, or the death of the participant.

Industry Context

This Form 4 filing reflects routine insider equity transactions common across publicly traded companies, where directors manage their compensation and equity holdings, often through pre-arranged 10b5-1 plans to comply with insider trading regulations.

Comparison to Industry Standards

  • The use of a Rule 10b5-1 plan for insider transactions is a standard corporate governance practice, aligning with best practices for managing potential insider trading concerns.
  • Deferred share plans for director compensation are common in the financial services industry, similar to those seen at peers like JPMorgan Chase & Co. (JPM) or Bank of America Corp. (BAC), allowing directors to align their long-term interests with the company's performance.

Corporate Governance

Change TypeDescriptionEffective DateImpact Assessment
Compensation Plan UsageDirectors may elect to defer fees into the Amended and Restated Directors' Deferred Share Sub-Plan to the KeyCorp Amended and Restated 2019 Equity Compensation Plan.N/AReinforces long-term alignment of director interests with shareholder value through equity-based compensation.

Stakeholder Impact

  • Shareholders: The director's increased deferred share holdings align their interests with long-term shareholder value. The use of a 10b5-1 plan promotes transparency and reduces concerns about opportunistic insider trading.
  • Employees: No direct impact mentioned.
  • Customers: No direct impact mentioned.
  • Suppliers: No direct impact mentioned.
  • Creditors: No direct impact mentioned.

Next Steps

  • Payment of deferred shares to Robin Hayes by January 1, 2028, or upon death.

Key Dates

DateDescription
12/31/2025Date of earliest transaction for deferred share acquisition.
01/01/2026Transaction date for the exercise of deferred shares into common shares.
01/05/2026Signature date of the reporting person's power of attorney.
01/01/2028Earliest date for payment of deferred shares, or upon participant's death.

Recommendation

hold

This Form 4 filing details routine, pre-planned insider transactions by a director, including the acquisition of deferred shares and conversion of others into common stock. While the acquisition of deferred shares by a director is a minor positive, indicating continued alignment of interests, these transactions are not material enough to warrant a change in investment recommendation. The filing provides no new information regarding the company's operational performance, financial health, or strategic direction that would alter a seasoned investor's current stance on KeyCorp stock.

Keywords

KeyCorp, KEY, Form 4, Insider Trading, Director Holdings, Deferred Shares, Common Shares, Equity Compensation, Robin Hayes, 10b5-1 Plan

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.